A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Clinical trial NCT06907485 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06907485
- Sponsor
- Costas Hadjipanayis
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.